2016 BCOP Recertification

Upcoming Events


Check out the latest edition of HOPA News!

HOPA News Volume 15 issue 3

Latest Discussions

HOPA Bulletin

  • Across many countries, a rapid escalation of the incidence of thyroid cancer has been observed, a surge that nonetheless underestimates the true extent of the disease. Most thyroid cancers now diagnosed comprise small, low-risk cancers that are incidentally found and are unlikely to cause harm. In many ways, prostate cancer similarly harbors a well-behaved subclinical reservoir, a long natural history, and superlative outcomes that have made active surveillance the de facto guideline recommendation for low-risk disease. This review highlights the parallels and differences between prostate cancer and thyroid cancer regarding screening, diagnosis, risk stratification and considerations for active surveillance.

Getting Started

Check out our user guide for further information.

Connect With Us